Cardiome names chief medical officer
Executive Summary
Former Abbott Divisional VP-Global Pharmaceutical Development Charles Fisher joins Cardiome as exec VP-clinical and regulatory affairs and chief medical officer, a newly created position. Fisher will report to CEO Robert Rieder and assume a leading role in the development of the antiarrythmic product RSD 1235 and CHF therapy oxypurinol...